The power of 'box a'

Expert Review of Vaccines

Volumn 2, Issue 1, 2003, Pages 1-3

  Offit, Paul A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYME DISEASE VACCINE; MEASLES MUMPS RUBELLA VACCINE;

AGE; AUTISM; CHILD HEALTH; CHRONIC ARTHRITIS; CONFIDENCE INTERVAL; EDITORIAL; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INFECTION PREVENTION; LYME DISEASE; MEASLES; MUMPS; PARENTAL BEHAVIOR; PRIORITY JOURNAL; RISK ASSESSMENT; RUBELLA; VACCINATION;

ADULT; ARTHRITIS; AUTISTIC DISORDER; CAUSALITY; CHILD, PRESCHOOL; COHORT STUDIES; DECISION MAKING; DENMARK; HUMANS; INFANT; LYME DISEASE VACCINES; MEASLES-MUMPS-RUBELLA VACCINE; MENTAL RETARDATION; PARENTS; PERTUSSIS VACCINE; PUBLIC OPINION; RETROSPECTIVE STUDIES; RISK; VACCINATION;

EID: 0038330374     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.2.1.1     Document Type: Editorial

References (22)

1. Autism: present challenges, future needs - why the increased rates? Committee on Government Reform, House of Representatives, 106th Congress, April 6th (2000).
2. Madsen KM, Hvid A, Vestergaard M et al. A population-based study of measles, mumps and rubella vaccination and autism. N. Engl. J. Med. 347, 1477-1482 (2002).
3. Taylor B, Miller E, Farrington P et al. Autism and measles, mumps and rubella vaccine: no epidemiologic evidence for a causal association. Lancet 353, 2026-2029 (1999).
4. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 19, 3632-3635 (2001).
5. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA 285, 1183-1185 (2001).
6. Kaye JA, Melero-Montes M, Jick H. Mumps, measles and rubella vaccine and the incidence of autism recorded bygeneral practitioners: a time trend analysis. Br. Med. J. 322, 460-463 (2001).
7. Taylor B, Miller E, Lingam R et al. Measles, mumps and rubella vaccination and bowel problems or developmental regression in children with autism: population study. Br. Med. J. 324, 393-396 (2002).
8. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumpsrubella-induced autism. Pediatrics 108, e58 (2001).
9. Mäkelä A, Nuorti P, Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110, 957-963 (2002).
10. Nisbett RE, Borgida E, Crandall R, Reed H. Popular induction: information is not necessarily informative. In: Judgement under uncertainty: heuristics and biases. Kahnemann D, Slovic P, Tversky A (Eds). Cambridge University Press, Cambridge, UK (1982).
11. Steere AC, Sikand VK, Meurice F et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outersurface lipoprotein A with adjuvant. N. Engl. J. Med. 339, 209-215 (1998).
12. Sigal LH, Zahradnik JM, Lavin P et al. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease. N. Engl. J. Med. 339, 216-222 (1998).
13. Steere AC, Gross D, Meyer AL, Huber BT. Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J. Autoimmunity 16, 263-268 (2001).
14. Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch. Dis. Child. 49, 46-49 (1974).
15. Gangarosa EJ, Galazka AM, Wolfe CR et al. Impact of antivaccine movements on pertussis control: the untold story. Lancet 351, 356-361 (1998).
16. Cody CL, Baraff LJ, Cherry JD et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pedriatics 68, 650-660 (1981).
17. Pollock TM, Morris J. A 7-year survey of disorders attributed to vaccination in Northwest Thames Region. Lancet 1, 753-757 (1983).
18. Walker AM, Jick H, Perera DR et al. Neurologic events following diphtheria-tetanus-pertussis immunization. Pediatrics 81, 345-349 (1988).
19. Griffin MR, Ray WA, Schaffner W et al. Risk of seizures and encephalopathy after immunization with diphtheria-tetanus-pertussis vaccine. JAMA 263, 1641-1645 (1990).
20. Shields WD, Nielsen C, Buch D et al. Relationship of pertussis immunization to the onset of neurologic disorders. J. Pediatr. 113, 801-805 (1988).
21. Gale JL, Thapa PB, Wassilak SGF et al. Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine: a population-based case-control study. JAMA 271, 37-41 (1994).
22. Golden GS. Pertussis vaccine and injury to the brain. J. Pediatr. 116, 854-861 (1990).